Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
MA03 - Clinomics and Genomics
- 10:30 - 12:00
- 9/08/2019
- Location: Colorado Springs (1994)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Heather A Wakelee, Wilfried Ernst Erich Eberhardt
-
+
MA03.05 - BRAF Mutations Are Associated with Increased Benefit from PD1/PDL1 Blockade Compared with Other Oncogenic Drivers in Non-Small Cell Lung Cancer
11:00 - 11:05 | Presenter: Marcelo Vailati Negrao | Author(s): Ferdinandos Skoulidis, Meagan Montesion, Katja Schulze, Ilze Bara, Vincent Shen, Sylvia Hu, Yasir Elamin, Xiuning Le, Michael E Goldberg, Chang-Jiun Wu, Jianhua Zhang, David S Barreto, Waree Rinsurongkawong, George R Simon, Jack Roth, Stephen Swisher, Jack Lee, Anne Tsao, Vassiliki A Papadimitrakopoulou, Don Lynn Gibbons, Bonnie Glisson, Vincent A Miller, Brian Alexander, Garrett M Frampton, Lee A Albacker, David S Shames, Jianjun Zhang, John Victor Heymach
- Abstract
Loading...
-
+
P1.14 - Targeted Therapy
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P1.14-08 - Activity of Poziotinib and Other 2nd-Gen Quinazoline EGFR TKIs in Atypical Exon18 and Acquired Osimertinib Resistance Mutants
09:45 - 09:45 | Presenter: Jacqulyne Ponville Robichaux | Author(s): Xiuning Le, Yasir Elamin, Monique Nilsson, Limei Hu, Junqin He, Fahao Zhang, Alissa Poteete, Huiying Sun, Waree Rinsurongkawong, Jason B Cross, John Victor Heymach
- Abstract
Loading... -
+
P1.14-17 - Genomic Evolution During TKI Treatment in Non-Small Cell Lung Cancer Patients With or Without Acquired T790M Mutation
09:45 - 09:45 | Presenter: Yanjun Xu | Author(s): Ying Jin, Hua Bao, Xiuning Le, Xiaojun Fan, Ming Tang, Yun Fan, Yiping Zhang, Xun Shi, Jun Zhao, Guangyuan Lou, Lan Shao, Qiong He, Chen Lin, Jianhua Zhang, P. Andrew Futreal, Ignacio Wistuba, John Victor Heymach, Xue Wu, Yang W. Shao, Junrong Yan, Yamei Chen, Ming Chen, Jianjun Zhang, Xinmin Yu
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P2.01-22 - ORCHARD: A Phase II Platform Study in Patients with Advanced NSCLC Who Have Progressed on First-Line Osimertinib Therapy
10:15 - 10:15 | Presenter: Helena A Yu | Author(s): Sarah B. Goldberg, Xiuning Le, Zofia Piotrowska, Paul Smith, Ilhem Mensi, Bistra Kirova, Juliann Chmielecki, Xiaocheng Li-Sucholeicki, Philip Szekeres, Gail Doughton, Gargi Patel, Philip J Jewsbury, Jonathan W. Riess
- Abstract
Loading...
-
+
P2.04 - Immuno-oncology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P2.04-90 - Nodal Immune Flare (NIF) Following Neoadjuvant Anti-PD-1 and Anti-CTLA-4 Therapy in Non-Small Cell Lung Cancer
10:15 - 10:15 | Presenter: Boris Sepesi | Author(s): Myrna C. B. Godoy, William N. William, Ara A Vaporciyan, Heather Lin, Cheuk Leung, Jack Lee, Kyle Gregory Mitchell, Annikka Weissferdt, Xiuning Le, Vincent Lam, Frank Fossella, Stephen Swisher, John Victor Heymach, Tina Cascone
- Abstract
Loading...
-
+
P2.14 - Targeted Therapy
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P2.14-24 - An Open-Label Randomized Phase II Study of Combining Osimertinib With and Without Ramucirumab in TKI-Naïve EGFR-Mutant Metastatic NSCLC
10:15 - 10:15 | Presenter: Xiuning Le | Author(s): Viola W. Zhu, Andreas Saltos, Petros Nikolinakos, Kathryn F Mileham, Vamsidhar Velcheti, Hatim Husain, Monique Nilsson, Hai Tran, Emily Roarty, Edward Kim, Sai-Hong Ignatius Ou, Rachel E. Sanborn, Jhanelle Elaine Gray, Kwok-Kin Wong, Nasser Hanna, Vassiliki A Papadimitrakopoulou, John Victor Heymach
- Abstract
Loading...
-
+
OA13 - Ideal Approach to Lung Resection and Novel Perioperative Therapy
- 11:30 - 13:00
- 9/10/2019
- Location: Toronto (1985)
- IASLC CME Accredited
- Type: Oral Session
- Track: Treatment of Early Stage/Localized Disease
- Moderators:Tomasz Grodzki, Kenji Suzuki
-
+
OA13.06 - Surgical Outcomes Following Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Non-Small Cell Lung Cancer - NEOSTAR Study
12:20 - 12:30 | Presenter: Boris Sepesi | Author(s): Tina Cascone, William N. William, Heather Lin, Cheuk Leung, Annikka Weissferdt, Garrett L Walsh, David Rice, Jack Roth, Reza J Mehran, Wayne L Hofstetter, Mara Antonoff, Frank Fossella, Frank E Mott, Xiuning Le, Ferdinandos Skoulidis, Jianjun Zhang, Lauren Averett Byers, Vincent Lam, Bonnie Glisson, Jonathan Kurie, George Blumenschein, Anne Tsao, Charles Lu, Mehmet Altan, Yasir Elamin, Don Lynn Gibbons, Vassiliki A Papadimitrakopoulou, Jack Lee, John Victor Heymach, Ara A Vaporciyan, Stephen Swisher
- Abstract
Loading...